###begin article-title 0
###xml 0 6 <span type="species:ncbi:9796">Equine</span>
###xml 79 84 <span type="species:ncbi:9796">horse</span>
Equine Multiple Congenital Ocular Anomalies maps to a 4.9 megabase interval on horse chromosome 6
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 840 847 840 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 883 888 883 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 984 989 984 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 0 6 <span type="species:ncbi:9796">Equine</span>
###xml 232 237 <span type="species:ncbi:9796">horse</span>
###xml 709 714 <span type="species:ncbi:9796">horse</span>
###xml 778 784 <span type="species:ncbi:9796">horses</span>
Equine Multiple Congenital Ocular Anomalies (MCOA) syndrome consists of a diverse set of abnormalities predominantly localized to the frontal part of the eye. The disease is in agreement with a codominant mode of inheritance in our horse material. Animals presumed to be heterozygous for the mutant allele have cysts originating from the temporal ciliary body, peripheral retina and/or iris. In contrast, animals predicted to be homozygous for the disease-causing allele possess a wide range of multiple abnormalities, including iridociliary and/or peripheral retinal cysts, iridocorneal angle abnormalities, cornea globosa, iris hypoplasia and congenital cataracts. MCOA is most common in the Rocky Mountain horse breed where it occurs at a high frequency among Silver colored horses. The Silver coat color is associated with mutations in PMEL17 that resides on ECA6q23. To map the MCOA locus we analyzed 11 genetic markers on ECA6q and herein describe a chromosome interval for the MCOA locus.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 367 373 367 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17</italic>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 475 480 475 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP5 </italic>
###xml 503 514 503 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17ex11 </italic>
###xml 540 545 540 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP6 </italic>
###xml 600 605 600 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 630 637 630 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 89 94 <span type="species:ncbi:9796">horse</span>
We performed linkage analysis within 17 paternal half-sib families of the Rocky Mountain horse breed. More than half of the 131 offspring had the Cyst phenotype and about one third had MCOA. Segregation data were obtained by genotyping 10 microsatellite markers most of which are positioned on ECA6q22-23, as well as the missense mutation for the Silver phenotype in PMEL17. Significant linkage was found between the MCOA locus and eight of the genetic markers, where marker UPP5 (Theta = 0, z = 12.3), PMEL17ex11 (Theta = 0, z = 19.0) and UPP6 (Theta = 0, z = 17.5) showed complete linkage with the MCOA locus. DNA sequencing of PMEL17 in affected and healthy control individuals did not reveal any additional mutations than the two mutations associated with the Silver coat color.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP5</italic>
###xml 127 138 127 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17ex11 </italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP6 </italic>
###xml 184 190 <span type="species:ncbi:9796">horses</span>
###xml 263 269 <span type="species:ncbi:9796">horses</span>
The MCOA locus can with high confidence be positioned within a 4.9 megabase (Mb) interval on ECA6q. The genotype data on UPP5, PMEL17ex11 and UPP6 strongly support the hypothesis that horses with the Cyst phenotype are heterozygous for the mutant allele and that horses with the MCOA phenotype are homozygous for the mutant allele.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 24 25 24 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1449 1450 1449 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1523 1524 1523 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1525 1526 1525 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1735 1736 1735 1736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 101 106 <span type="species:ncbi:9796">horse</span>
###xml 352 358 <span type="species:ncbi:9796">horses</span>
###xml 438 444 <span type="species:ncbi:9796">horses</span>
###xml 532 538 <span type="species:ncbi:9796">horses</span>
###xml 738 744 <span type="species:ncbi:9796">horses</span>
###xml 834 839 <span type="species:ncbi:9796">horse</span>
###xml 1191 1196 <span type="species:ncbi:9796">horse</span>
###xml 1441 1447 <span type="species:ncbi:9796">Horses</span>
###xml 1515 1521 <span type="species:ncbi:9796">horses</span>
###xml 1645 1649 <span type="species:ncbi:9615">dogs</span>
In 1999, Ramsey et al. [1] described a wide range of congenital ocular defects in the Rocky Mountain horse originally referred to as Anterior Segment Dysgenesis syndrome. More recently, the syndrome has been referred to as Multiple Congenital Ocular Anomalies (MCOA), as described by Grahn et al. [2]. Ocular abnormalities are in general quite rare in horses, accounting for less than five percent of the congenital disorders reported in horses [3,4]. Conversely, eye abnormalities were encountered in approximately half of the 514 horses examined in Ramsey's study. The high incidence of ocular abnormalities in this breed is most likely due to a founder effect. Pedigree examination has revealed that a large proportion of the affected horses have a common ancestor, a stallion that is one of the few founders of the Rocky Mountain horse breed. The fact that five out of seven of the ancestral stallion's first-generation offspring had ocular abnormalities suggests that this individual did indeed carry the mutant allele. Extensive breeding from this foundation sire's offspring has propagated the causative mutation(s), leading to a high frequency of MCOA syndrome in the Rocky Mountain horse population. There are numerous examples where intense and selective breeding of a few lineages has led to a high occurrence of undesired traits in domesticated animals. Examples of such are hyperkalaemic periodic paralysis (HYPP) among Quarter Horses [5] and severe combined immunodeficiency disease (SCID) in Arabian horses [6,7]. The negative effects of breed development from a limited number of individuals and/or inbreeding is also evident in dogs, with several cases of high incidence of inherited diseases within modern purebreds [8].
###end p 9
###begin p 10
###xml 56 57 56 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 688 689 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 813 817 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b&#8211;d</xref>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 822 823 822 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1312 1313 1312 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1314 1316 1314 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 76 82 <span type="species:ncbi:9796">horses</span>
###xml 218 224 <span type="species:ncbi:9796">Horses</span>
###xml 380 386 <span type="species:ncbi:9796">horses</span>
###xml 440 446 <span type="species:ncbi:9796">horses</span>
###xml 574 580 <span type="species:ncbi:9796">horses</span>
###xml 717 723 <span type="species:ncbi:9796">horses</span>
###xml 1190 1195 <span type="species:ncbi:9796">horse</span>
The MCOA syndrome has a codominant mode of inheritance [9] and the affected horses can be separated into two groups depending on the type of ocular defects that they possess; the Cyst phenotype and the MCOA phenotype. Horses referred to as having the Cyst phenotype are presumed to be heterozygous for the mutant allele and have a minor form of ocular abnormalities compared with horses carrying two copies [1,9]. The presumed heterozygous horses have cysts that originate from the temporal ciliary body, peripheral retina and/or iris (Figure 1a). A smaller number of these horses also have moderate retinal dysplasia or retinal detachment that appears to be an extension of these cysts [1]. The predicted homozygous horses have multiple abnormalities, primarily affecting the anterior segment of the eye (Figure 1b-d) [1,9]. They encompass all clinical signs included in the Cyst phenotype concurrent with iris hypoplasia, iridocorneal angle abnormalities, miosis, congenital cataracts, cornea globosa, iridocorneal adhesions and opacification, nuclear cataract as well as pupils with a decreased or absent light response and that do not dilate when administered mydriatic drugs. A single horse does not necessarily possess all of these clinical signs and there are additional defects detected less frequently [1,10].
###end p 10
###begin p 11
###xml 0 31 0 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Clinical signs of MCOA syndrome</bold>
###xml 33 34 33 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 208 209 208 209 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 625 626 625 626 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 765 766 765 766 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 128 133 <span type="species:ncbi:9796">horse</span>
###xml 259 264 <span type="species:ncbi:9796">horse</span>
###xml 667 672 <span type="species:ncbi:9796">Horse</span>
###xml 807 812 <span type="species:ncbi:9796">Horse</span>
Clinical signs of MCOA syndrome. A. Oblique profile images of the lateral anterior segment of the right eye of a Rocky Mountain horse. A multiloculated cyst arising from the anterior ciliary body is present. B. Photograph of the right eye of a Rocky Mountain horse with ectropion uvea, dyscoria, cataract, and lens subluxation. The granula iridica is hypoplastic, the pupil is misshapen, and complete circumferential ectropion uvea is present. Nuclear cataract of the nuclear-cortical junction is present. Vitreous is present in the anterior chamber between the iris and lens secondary to posterior ventral lens subluxation. C. Profile photograph of a Rocky Mountain Horse with Cornea Globosa. Note the anterior protrusion of the cornea and large corneal diameter. D. Profile photograph of a Rocky Mountain Horse with a normal cornea. Note the normal corneal curvature and diameter.
###end p 11
###begin p 12
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 832 839 832 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Silver </italic>
###xml 1156 1163 1156 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Silver </italic>
###xml 1411 1412 1411 1412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1433 1438 1433 1438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1441 1443 1441 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1541 1548 1541 1548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17)</italic>
###xml 1622 1629 1622 1629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 1633 1640 1633 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Silver </italic>
###xml 1800 1807 1800 1807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Silver </italic>
###xml 2058 2060 2058 2060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 2245 2252 2245 2252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 2337 2351 2337 2351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fading vision </italic>
###xml 2352 2354 2352 2354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 2442 2444 2442 2444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 2472 2474 2472 2474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 2526 2533 2526 2533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 2552 2557 2552 2557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 2560 2562 2560 2562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 73 78 <span type="species:ncbi:9796">horse</span>
###xml 128 134 <span type="species:ncbi:9796">horses</span>
###xml 219 225 <span type="species:ncbi:9796">horses</span>
###xml 372 378 <span type="species:ncbi:9796">horses</span>
###xml 467 473 <span type="species:ncbi:9796">horses</span>
###xml 527 533 <span type="species:ncbi:9796">horses</span>
###xml 681 686 <span type="species:ncbi:9796">horse</span>
###xml 800 806 <span type="species:ncbi:9796">horses</span>
###xml 1074 1079 <span type="species:ncbi:9796">horse</span>
###xml 1828 1833 <span type="species:ncbi:9796">horse</span>
###xml 2048 2056 <span type="species:ncbi:9031">chickens</span>
###xml 2320 2329 <span type="species:ncbi:7955">zebrafish</span>
MCOA has been well studied in a limited population of the Rocky Mountain horse breed, where it was found to be most frequent in horses with the Silver coat color (also known as Chocolate coat color) [1]. Silver colored horses are especially desired in this breed and thus used more frequently for breeding. The consequence is an unusually high frequency of Silver colored horses (approximately 55% of registered individuals are shown as Silver/Chocolate), as well as horses with MCOA syndrome. The percentage of Silver colored horses from different breeds that also display the Cyst phenotype or MCOA is unknown, simply because this has not been investigated. In many of the other horse breeds that have the Silver coat color, it is present in a much lower frequency. As a result most Silver colored horses are heterozygous for the Silver mutation and hence most likely carry the milder form of this eye disorder that is more difficult to detect. The investigation about the correlation between the Silver coat color and MCOA is further complicated by the fact that certain horse coat colors, for example chestnut (red), display no or little effect of the Silver mutation. The Silver color is characterized by dilution of black pigment in the hair to white or grey. The dilution is most visible in the long hairs of the mane and tail, where the dilution results in a silver or white mane and tail color (Figure 2). In 2006, Brunberg et al. [11] reported that the Silver coat color is associated with mutations in pre-melanosomal protein 17 (PMEL17). This conclusion was based on the observation of no recombinants between PMEL17 and Silver in a pedigree and the identification of a haplotype, composed of sequence variations in intron 9 and exon 11, showing complete concordance with the presence of Silver across six different horse breeds. In that paper, we also describe a candidate causative missense mutation ARG618Cys that is a non-conservative substitution at a conserved site and mutations in the near vicinity cause a similar phenotype in chickens [12]. The intronic mutation was found less likely to be causative for Silver since it resides in an intronic region not well conserved among mammalian species. Interestingly, mutations in PMEL17 are known to give ocular abnormalities and visual impairment in the zebrafish mutant fading vision [13]. Microphthalmia and colobomas have also been described in merle patterned Dachshunds [14] and Australian Shepherds [15], a patterning associated with a SINE insertion in PMEL17 according to Clark et al. [16].
###end p 12
###begin p 13
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A Silver colored Rocky Mountain Horse</bold>
###xml 32 37 <span type="species:ncbi:9796">Horse</span>
###xml 180 185 <span type="species:ncbi:9796">horse</span>
###xml 339 344 <span type="species:ncbi:9796">horse</span>
A Silver colored Rocky Mountain Horse. The typical shiny white mane and tail as well as a slightly diluted body color with dapples is seen in this genetically black Silver colored horse. The phenotype is caused by dilution of eumelanin in the hair to white or grey. The dilution is most visible in the long hairs of the mane and tail. The horse has also been diagnosed with MCOA.
###end p 13
###begin p 14
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
In this study we firmly positioned the MCOA locus to a 4.9 Mb region on ECA6q. Further, we describe complete linkage between three genetic markers in the interval and the MCOA locus.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
Genotyping and Linkage analysis
###end title 16
###begin p 17
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 367 368 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 489 496 489 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 633 634 633 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 697 704 697 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 845 846 845 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1108 1113 1108 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 1167 1168 1167 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1339 1344 1339 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1352 1353 1352 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1432 1441 1432 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UCDEQ465 </italic>
###xml 1445 1450 1445 1450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP7 </italic>
###xml 1462 1463 1462 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 80 85 <span type="species:ncbi:9796">horse</span>
###xml 1492 1497 <span type="species:ncbi:9796">horse</span>
###xml 1540 1545 <span type="species:ncbi:9796">horse</span>
We performed linkage analysis by genotyping 17 paternal half-sib Rocky Mountain horse families segregating for the MCOA locus. The number of offspring sired from each stallion ranged from one to 29 with an average of 7.7 offspring per sire (Table 1). DNA was available from 41 out of the 94 different mares within the pedigree. We genotyped 11 genetic markers (Table 2), spanning approximately 45 Mb on ECA6q. The rationale for selecting this particular chromosome and region was that the PMEL17 locus is positioned on ECA6q23. Four families were used for identification of an initial and broader interval for the MCOA locus (Figure 3). Genotyping was restricted to cover a narrower region around PMEL17 for the remaining 13 families. For simplicity we only present the total number of informative meioses per marker, which is compiled in Table 3. According to CHROMPIC [17], one individual was a double recombinant over a very small genetic distance and was excluded from the analysis since it most likely represents a genotyping error. Interestingly, one offspring showed non-Mendelian inheritance for the MCOA locus. Although bred from a dam (marked red in Figure 3) without any detectable ocular abnormalities, this individual had the MCOA phenotype. The particular mare was, therefore, reported to be a case of nonpenetrance by Ewart et al. 2000 [9]. Genotyping revealed that this mare was heterozygous for all markers between UCDEQ465 and UPP7 (see Figure 4) and thus might represent a horse with a phenotyping error. This particular horse will be re-examined.
###end p 17
###begin p 18
Description of the pedigrees and extent of genotyping in each family
###end p 18
###begin p 19
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
1Phenotypes of the offspring are compiled within parenthesis (MCOA, Cyst, Healthy)
###end p 19
###begin p 20
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
2Phenotypes of the dams are compiled within parenthesis (MCOA, Cyst, Healthy, Unexamined)
###end p 20
###begin p 21
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
3Phenotypes of the dams are compiled within parenthesis (MCOA, Cyst, Healthy)
###end p 21
###begin p 22
###xml 46 48 46 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
Genetic markers used in the linkage analysis [18,27,28,11]
###end p 22
###begin p 23
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
Two-point analysis between the MCOA locus and ECA6q markers
###end p 23
###begin p 24
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pedigrees</bold>
###xml 168 180 168 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17ex11) </italic>
###xml 459 470 459 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17ex11 </italic>
###xml 616 621 616 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 221 227 <span type="species:ncbi:9796">horses</span>
###xml 288 294 <span type="species:ncbi:9796">horses</span>
###xml 339 345 <span type="species:ncbi:9796">horses</span>
###xml 380 386 <span type="species:ncbi:9796">horses</span>
Pedigrees. Pedigrees of four of the half-sib families (sired by stallion 1-4) used in this study. Phenotype information along with genotype data on one genetic marker (PMEL17ex11) is shown for all individuals. Unaffected horses are indicated by open symbols, half filled symbols indicate horses affected with cysts, solid symbols indicate horses affected with MCOA and unexamined horses are indicated by symbols enclosing a question mark. We selected the SNP PMEL17ex11 to represent the near perfect correlation between phenotype and genotype of the three markers in our interval that show complete linkage with the MCOA locus. The only discrepancy (marked in red) is a healthy dam with a heterozygous genotype. However, since she has produced two MCOA affected offspring, this dam is most likely a case where the position and/or size of the cysts make them extremely difficult to detect. NG: Not Genotyped (as DNA was not available).
###end p 24
###begin p 25
###xml 0 35 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Positions of analyzed ECA6q markers</bold>
###xml 84 94 84 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17ex11</italic>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP5 </italic>
###xml 265 276 265 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17ex11 </italic>
###xml 289 294 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP6 </italic>
###xml 419 426 419 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TKY412 </italic>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP7</italic>
Positions of analyzed ECA6q markers. Ten microsatellite markers and one SNP marker (PMEL17ex11) spanning approximately 45.2 Mb were included in this study. Three markers showed complete linkage (recombination fraction = 0.00) with the MCOA locus; UPP5 (z = 10.84), PMEL17ex11 (z = 12.64), UPP6 (z = 11.14). Our result can position the MCOA susceptibility locus with high confidence to the 4.9 megabase interval between TKY412 and UPP7.
###end p 25
###begin p 26
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 151 156 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 184 189 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP5 </italic>
###xml 202 213 198 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17ex11 </italic>
###xml 229 234 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP6 </italic>
###xml 254 260 250 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UM015 </italic>
###xml 295 303 291 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UCDEQ465</italic>
###xml 368 373 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 391 392 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 517 519 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 533 538 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 612 617 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 712 719 708 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TKY412 </italic>
###xml 723 728 719 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP7 </italic>
###xml 768 773 <span type="species:ncbi:9796">horse</span>
The results of the TWO-POINT analysis including all 17 paternal families are compiled in Table 3. We found complete linkage (Theta = 0.00) between the MCOA locus and the three markers UPP5 (z = 10.84), PMEL17ex11 (z = 12.64) and UPP6 (z = 11.14). Marker UM015 is approximately 27 Mb upstream of UCDEQ465, which explains the lack of linkage between this marker and the MCOA locus (see Figure 4). We used the BUILD option with a fixed order of markers according to the order of markers in Ensembl (EquCab 2, Sep 2007) [18] and allowed MCOA to be inserted. Since three markers did not have any recombination to the MCOA locus, the disease locus could be incorporated equally likely anywhere in the interval between TKY412 and UPP7 (log10_like = -25.24). According to the horse genome sequence in Ensembl, these two markers are positioned on Chr6:70589360 and Chr6:75475262, respectively. The current MCOA interval thus spans approximately 4.9 Mb. There is one reliable recombinant on either side of this interval.
###end p 26
###begin title 27
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
Sequencing of PMEL17 and genotyping of SNPs
###end title 27
###begin p 28
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 310 317 310 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1085 1096 1085 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17ex11 </italic>
###xml 1112 1117 1112 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP5 </italic>
###xml 1121 1126 1121 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP6 </italic>
###xml 1160 1165 1160 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 1283 1294 1283 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17ex11 </italic>
###xml 1335 1336 1335 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1496 1497 1496 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1710 1714 1710 1714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP5</italic>
###xml 1716 1727 1716 1727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17ex11 </italic>
###xml 1731 1736 1731 1736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP6 </italic>
###xml 97 106 <span type="species:ncbi:7955">zebrafish</span>
###xml 159 163 <span type="species:ncbi:9615">dogs</span>
###xml 349 355 <span type="species:ncbi:9796">horses</span>
###xml 363 369 <span type="species:ncbi:9796">horses</span>
###xml 767 773 <span type="species:ncbi:9796">horses</span>
###xml 896 902 <span type="species:ncbi:9796">horses</span>
###xml 985 991 <span type="species:ncbi:9796">horses</span>
###xml 1243 1248 <span type="species:ncbi:9796">horse</span>
###xml 1773 1779 <span type="species:ncbi:9796">horses</span>
###xml 1852 1858 <span type="species:ncbi:9796">horses</span>
PMEL17 is a candidate gene for MCOA because of its documented effect on ocular phenotypes in the zebrafish as well as described eye defects in merle-patterned dogs. In addition, the SNP marker positioned within the gene showed complete linkage to the MCOA locus in our linkage analysis. We therefore sequenced PMEL17 in three healthy Rocky Mountain horses, three horses with the MCOA phenotype and three with the Cyst phenotype. In total, 6400 bp was sequenced, covering all exons and UTRs, 370 bp upstream, 210 bp downstream as well as full coverage of all introns except four. No additional polymorphism that associated completely with the disease could be detected other than the two SNPs identified in Brunberg et al. 2006 [11]. In these two SNPs, all three MCOA horses were homozygous (Exon 11: T/T and Intron 9: T/T) for the alleles associated with the Silver coat color, the three healthy horses were homozygous (Exon 11: C/C and Intron 9: A/A) for the opposite alleles and the horses with the Cyst phenotype were heterozygous (Exon 11: T/C and Intron 9: T/A) in both SNPs. The PMEL17ex11 SNP (as well as UPP5 and UPP6 also in complete linkage with the MCOA locus) shows a near perfect correlation between phenotype and genotype in our horse material. Genotype information on PMEL17ex11 is shown in the four pedigrees in Figure 3. The only discrepancy is the healthy dam discussed above (Genotyping and Linkage analysis section) with a heterozygous genotype (marked in red color in Figure 3). However, since she has produced two MCOA affected offspring, this dam is most likely a case where the position and/or size of the cysts make them extremely difficult to detect. In summary, the genotype data on UPP5, PMEL17ex11 and UPP6 strongly support the hypothesis that horses with the Cyst phenotype are heterozygous for the mutant allele and that horses with the MCOA phenotype are homozygous for the mutant allele.
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 191 198 191 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TKY412 </italic>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP7</italic>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 828 835 828 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 1714 1724 1714 1724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Small eye </italic>
###xml 1770 1774 1770 1774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAX6</italic>
###xml 1776 1786 1776 1786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Small eye </italic>
###xml 1920 1922 1920 1922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1931 1936 1931 1936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1939 1940 1939 1940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 2183 2192 2183 2192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UCDEQ465 </italic>
###xml 2196 2200 2196 2200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP7</italic>
###xml 2457 2462 2457 2462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 2465 2466 2465 2466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 72 77 <span type="species:ncbi:9796">horse</span>
###xml 567 572 <span type="species:ncbi:9796">horse</span>
###xml 1042 1047 <span type="species:ncbi:9606">human</span>
###xml 1161 1166 <span type="species:ncbi:9606">human</span>
###xml 1171 1176 <span type="species:ncbi:9796">horse</span>
###xml 1190 1195 <span type="species:ncbi:9796">horse</span>
###xml 1235 1240 <span type="species:ncbi:9606">human</span>
###xml 1403 1409 <span type="species:ncbi:9796">horses</span>
###xml 1498 1504 <span type="species:ncbi:9796">horses</span>
###xml 1562 1568 <span type="species:ncbi:9796">horses</span>
###xml 1706 1709 <span type="species:ncbi:9606">man</span>
###xml 1727 1731 <span type="species:ncbi:10090">mice</span>
###xml 1786 1790 <span type="species:ncbi:10090">mice</span>
###xml 1856 1860 <span type="species:ncbi:10090">mice</span>
In the current study we have localized the MCOA locus to an interval on horse chromosome 6q by linkage mapping. The locus is positioned within a 4.9 Mb interval between microsatellite marker TKY412 and UPP7. This conclusion is based on one reliable recombinant on either side of the identified region. These two recombinant offspring were genotyped for all markers used in this study and the recombination events were clearly visualized by using the CHROMPIC-option in CRIMAP [17]. The order of markers could confidently be established through the publicly available horse genome sequence generated by The Broad Institute at MIT and Harvard [19]. We used the Ensembl genome browser to assess the precise position of genotyped markers. The UCSC genome browser utilizes the initial draft assembly (EquCab1). The contig containing PMEL17 is not anchored to a chromosome in that version. This problem had been solved in the second assembly (EquCab2), which is used by Ensembl. By blasting the sequence adjacent to our genetic markers against the human genome sequence (Ensembl, NCBI 36 assembly) we could conclude that the order of these sequences are identical in human and horse and that the horse MCOA region corresponds to a region on human chromosome 12 (HSA12). Further, we provide molecular genetic evidence that the MCOA syndrome is in agreement with a codominant mode of inheritance. MCOA affected horses were homozygous for all three markers that were completely linked to the disease locus, horses with the Cyst phenotype were heterozygous, while healthy horses had a different set of alleles. Dosage effects are present in developmental eye disorders in other species, like for example aniridia in man and Small eye in mice, that are both caused by mutations in PAX6. Small eye mice that are heterozygous display iris hypoplasia whereas homozygous mice lack eyes, nasal cavities and display brain abnormalities [20]. Ewart et al. [9] reported a limited number of nonpenetrance cases for the Cyst phenotype. One of these healthy, predicted nonpenetrance cases was included in our analysis. We could confirm that this individual was indeed heterozygous for all markers between UCDEQ465 and UPP7, which explains the production of an MCOA offspring. The occurrence of nonpenetrance might be attributable to difficulties in detecting small cysts if situated just posterior to the iris. However, as most of the nonpenetrance cases were clustered by Ewart et al. [9] to a specific branch of the pedigree, the potential presence of epistatic interactions between a modifier gene and the susceptibility locus cannot be excluded.
###end p 30
###begin p 31
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 465 472 465 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Silver </italic>
###xml 503 510 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 740 747 740 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Silver </italic>
###xml 761 766 761 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 916 922 916 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17</italic>
###xml 937 944 937 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 1036 1050 1036 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fading vision </italic>
###xml 1156 1158 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1422 1429 1422 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 1430 1432 1430 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1464 1466 1464 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1494 1496 1494 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1696 1701 1696 1701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1704 1706 1704 1706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 282 288 <span type="species:ncbi:9796">horses</span>
###xml 416 422 <span type="species:ncbi:9796">horses</span>
###xml 831 836 <span type="species:ncbi:9796">horse</span>
###xml 1019 1028 <span type="species:ncbi:7955">Zebrafish</span>
###xml 1329 1333 <span type="species:ncbi:9615">dogs</span>
###xml 1619 1624 <span type="species:ncbi:9606">human</span>
###xml 1718 1727 <span type="species:ncbi:7955">zebrafish</span>
###xml 1736 1739 <span type="species:ncbi:9615">dog</span>
###xml 1910 1916 <span type="species:ncbi:9796">horses</span>
It is possible that the causative mutation for MCOA is actually the same missense mutation in PMEL17 that causes the Silver coat color. However, this hypothesis is challenged by the fact that MCOA-like ocular abnormalities are not known to be present among Silver colored Icelandic horses. To investigate this further, we are arranging for a veterinary ophthalmologist to examine a number a Silver colored Icelandic horses, including one that is homozygous for the Silver mutation. We are not excluding PMEL17 as the causative gene for MCOA but since our 4.9 Mb region contains numerous genes we are planning a positional cloning approach to narrow down the region before further investigation of any one candidate. It is possible that the Silver locus and the MCOA locus are merely in linkage disequilibrium in the Rocky Mountain horse breed and that the true causative mutation is positioned in close proximity to PMEL17. Mutations in PMEL17 are known to associate with ocular abnormalities in two other species. The Zebrafish mutant fading vision demonstrates hypopigmentation in the retinal pigment epithelium (RPE) accompanied with vision impairment [13]. This phenotype is caused by a nonsense mutation, which expects to generate a truncated protein that lacks the terminal 355 amino acid residues. The merle patterning in dogs is associated with a SINE element insertion at the boundary of intron 10 and exon 11 in PMEL17 [16]. Merle homozygous Dachshunds [14] and Australian Shepherds [15] frequently have ocular defects such as microphthalmia, cataract and colobomas. These defects are similar to those of the human auditory-pigmentation disorder Waardenburg syndrome according to Clark et al. [16]. Both the zebrafish and the dog mutants show pigmentation defects in both the coat and in the retinal pigment epithelium (RPE). Neither of these two phenotypes is identical with the defects observed in horses with the MCOA syndrome.
###end p 31
###begin p 32
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 839 844 839 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PITX2</italic>
###xml 846 851 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FOXC1</italic>
###xml 853 857 853 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAX6</italic>
###xml 859 865 859 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FOXE3 </italic>
###xml 869 875 869 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LXM1B </italic>
###xml 879 883 879 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAF </italic>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 27 32 <span type="species:ncbi:9796">horse</span>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 195 201 <span type="species:ncbi:9606">humans</span>
###xml 297 302 <span type="species:ncbi:9606">human</span>
###xml 331 337 <span type="species:ncbi:9796">equine</span>
###xml 468 474 <span type="species:ncbi:9606">humans</span>
###xml 579 585 <span type="species:ncbi:9606">humans</span>
###xml 816 821 <span type="species:ncbi:9606">human</span>
###xml 931 936 <span type="species:ncbi:9796">horse</span>
###xml 980 985 <span type="species:ncbi:9796">horse</span>
###xml 1029 1034 <span type="species:ncbi:9606">human</span>
MCOA in the Rocky Mountain horse clearly has some overlapping phenotypes with human Anterior Segment Dysgenesis, ASD, (Bengt Schepke pers. comm.). Clinical classifications have been difficult in humans because of the complex nature of the disease [21]. Therefore, to precisely state if any of the human disorders are homologous to equine MCOA is not a simple task. Axenfeld-Rieger syndrome, Peters anomaly, Iris hypoplasia, Primary congenital glaucoma and Aniridia in humans do all fall under the spectrum of ASD [21]. Anterior Segment Dysgenesis is genetically heterogeneous in humans. Mutations in several different genes can cause the same clinical condition. Further, the same mutation in different individuals can cause different forms of ASD [21]. Mutations in several transcription factors are known to cause human ASD, for example PITX2, FOXC1, PAX6, FOXE3 and LXM1B and MAF [22]. None of these genes are positioned in the horse MCOA interval. However, the Rocky Mountain horse could at least serve as a useful model for human cornea globosa with iris hypoplasia and congenital miosis.
###end p 32
###begin p 33
###xml 0 6 <span type="species:ncbi:9796">Equine</span>
###xml 282 287 <span type="species:ncbi:9796">horse</span>
Equine MCOA is generally not detectable for the untrained eye, especially in its heterozygous state, which leaves the breeders unaware of the problem. This fact, together with the close linkage to the popular Silver coat color has propagated the mutant allele in the Rocky Mountain horse population. Thus, there is a real need for identifying the causative gene and subsequently developing a genetic test to allow for informed breeding decisions.
###end p 33
###begin p 34
###xml 1004 1005 1004 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 334 340 <span type="species:ncbi:9796">horses</span>
###xml 428 434 <span type="species:ncbi:9796">horses</span>
###xml 794 799 <span type="species:ncbi:9796">Horse</span>
###xml 826 831 <span type="species:ncbi:9796">Horse</span>
###xml 892 897 <span type="species:ncbi:9796">horse</span>
###xml 943 948 <span type="species:ncbi:9796">Horse</span>
###xml 964 969 <span type="species:ncbi:9796">horse</span>
###xml 996 1002 <span type="species:ncbi:9796">horses</span>
Although linkage analysis is a powerful method for identification of chromosome regions for monogenic traits, it is limited in its capacity to identify the underlying gene. However, linkage analysis in combination with a subsequent identity-by-descent mapping strategy utilizing more distantly related and/or unrelated Rocky Mountain horses provides a better resolution. The mutation containing haplotype shared among unrelated horses are much smaller than in family materials. Detection of causative mutation(s) is facilitated even further if the study is expanded to other breeds having the same phenotype. The MCOA syndrome is present among other breeds and we plan to use these in our future fine mapping studies. Identical ocular lesions have been observed in the Kentucky Mountain Saddle Horse and the Mountain Pleasure Horse. These two breeds are closely related to the Rocky Mountain horse. The phenotype is also present in the Morgan Horse, Belgian Draft horse and in American Miniature horses [1]. Thus, future studies will involve haplotype analysis of the MCOA region in other breeds known to carry MCOA syndrome. This strategy will, of course, be most effective if no locus heterogeneity exist for MCOA.
###end p 34
###begin title 35
Conclusion
###end title 35
###begin p 36
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP5</italic>
###xml 98 109 98 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17ex11 </italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP6</italic>
###xml 219 226 219 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TKY412 </italic>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UPP7</italic>
###xml 340 346 <span type="species:ncbi:9796">Horses</span>
We have mapped the MCOA locus to ECA6q, with complete linkage to the three genetic markers; UPP5, PMEL17ex11 and UPP6. The locus can with high confidence be positioned to a 4.9 Mb interval between microsatellite marker TKY412 and UPP7. Moreover, our results show that the disease is in agreement with a true codominant mode of inheritance. Horses with the most severe phenotype, displaying multiple ocular abnormalities, are homozygous across the MCOA interval while the group of animals having minor clinical signs is heterozygous.
###end p 36
###begin title 37
Methods
###end title 37
###begin title 38
Pedigrees
###end title 38
###begin p 39
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1019 1020 1019 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 69 74 <span type="species:ncbi:9796">horse</span>
###xml 230 235 <span type="species:ncbi:9796">horse</span>
###xml 402 408 <span type="species:ncbi:9796">horses</span>
###xml 474 480 <span type="species:ncbi:9796">horses</span>
This study included exclusively animals listed in the Rocky Mountain horse breed registrar. Seventeen paternal half-sib families where MCOA is segregating were selected for linkage analysis. To show the inheritance of MCOA in our horse material, pedigrees from four of the stallions are depicted in Figure 3. One hundred thirty-one offspring were contained within the pedigree where more than half (70 horses) of the offspring had the Cyst phenotype and about one third (38 horses) had MCOA. Out of the 94 different dams (with an average of 1.4 offspring per dam) included in the pedigree, DNA was available from 41. Out of these, eight had MCOA, 21 had the cyst phenotype and 12 were healthy. All stallions except one were predicted heterozygous for the disease i.e. had the Cyst phenotype. The one stallion was healthy and had only two offspring. The number of offspring and dams of each family, as well as the number of individuals in each phenotype category (MCOA, Cyst or healthy) per family are compiled in Table 1.
###end p 39
###begin title 40
Phenotype assessment
###end title 40
###begin p 41
###xml 63 64 63 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 65 66 65 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 883 888 883 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 891 892 891 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 558 564 <span type="species:ncbi:9796">horses</span>
###xml 623 629 <span type="species:ncbi:9796">horses</span>
###xml 698 704 <span type="species:ncbi:9796">horses</span>
Assessment of phenotype was performed as described previously [1,9]. Briefly, pupillary light reflex was first assessed and further ophthalmic examination was conducted subsequent to pupillary dilation with 1% tropicamide instilled in the conjunctival fornix. Examination included direct, focal and diffuse slit lamp biomicroscopy, indirect ophthalmoscopy and applanation tonometry. The posterior segments of the eyes have been examined along with the anterior parts. The examinations revealed abnormalities of the posterior segments along with cysts in all horses we predict to be homozygous, as well as a fraction of the horses predicted to be heterozygous [9]. Data on histology for part of the horses used in this study, including findings of retinal dysplasia with changes in both the neurosensory retinal epithelium and the retinal pigmented epithelium are described in Ramsey et al. [1]. Blood samples were collected for DNA isolation at the time of clinical examination. The phenotyping was approved by the Michigan State University Institutional Animal Use and Care Ethics Committee.
###end p 41
###begin title 42
Genetic markers, genotyping and linkage analysis
###end title 42
###begin p 43
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 651 652 650 651 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1159 1164 1149 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1167 1169 1157 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1193 1195 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1713 1718 1699 1704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCOA </italic>
###xml 1794 1796 1780 1782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 195 200 <span type="species:ncbi:9796">horse</span>
###xml 1406 1411 <span type="species:ncbi:9796">horse</span>
###xml 1466 1471 <span type="species:ncbi:9796">horse</span>
###xml 1520 1525 <span type="species:ncbi:9796">horse</span>
###xml 1771 1776 <span type="species:ncbi:9796">horse</span>
We genotyped eleven genetic markers covering 45.2 Mb (Table 2) of ECA6q. These included five previously identified microsatellite markers and five novel microsatellites markers attained from the horse genome sequence (EquCab1 Jan. 2007) [23] by displaying tracks from simple tandem repeats recognized by Tandem Repeats Finder [24]. The SNP in exon 11 of PMEL17 that is associated with the Silver coat color [11] was also utilized as a marker. Primers for novel microsatellites were designed using Primer3 [25]. The PCR reactions for amplifying microsatellites were carried out separately and in a total volume of 10 mul; 40 ng genomic DNA, 2.5 mM MgCl2, 1x PCR Gold buffer, 0.75 units AmpliTaq Gold polymerase, 0.24 mM dNTP, 0.1 mM forward primer, 1.0 mM reverse primer, 1.0 mM labeled M13 primer. The M13 primers were labeled with FAM or TET. Amplified fragments were multiplexed when possible and separated using a MegaBACEtrade mark1000 instrument according to manufactures instructions. The result was analyzed in Genetic Profiler version 2.4 (Amersham Biosciences). SNP genotype assessment was done by pyrosequencing essentially as described in Pielberg et al. [26]. CRI-MAP version 2.4 [17] was used to analyze linkage between the markers and the MCOA susceptibility locus. Since the disease is codominant, it is possible to score each individuals genotype on the basis of their phenotype. A healthy horse was scored as homozygous for healthy alleles, an MCOA horse as homozygous for disease causing alleles and a horse with the Cyst phenotype as heterozygous. The TWO-POINT option was used to calculate recombination fractions (Theta) and LOD scores. BUILD was used to give the most likely position of the MCOA locus after positioning all markers according to the horse genome sequence [18]. The output of CHROMPIC identified unlikely double recombinants that could reveal genotyping errors.
###end p 43
###begin title 44
Sequencing of PMEL17
###end title 44
###begin p 45
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 358 365 358 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
Primer sequences used to amplify PMEL17 can be found in Brunberg et al. [11]. Some additional novel primers were designed using Primer 3 [25], see additional file 1: Table 4. The reactions were carried out as described in [11] and results were analyzed in CodonCode Aligner version 1.6.3 (CodonCode Corporation, Dedham, MA). All eleven exons and both UTR of PMEL17 were sequenced. Further, all introns were fully sequenced except 1, 3, 6 and 10. Seventy base pairs (bp) were sequenced into each side of intron 1. Thirty bp were sequenced at the beginning of intron 3 and 80 bp at the end. Intron 6 was sequenced 390 and 590 bp at the start and end, respectively and intron 10 was sequenced 370 bp and 200 bp, respectively. We also sequenced approximately 370 bp upstream and 210 bp downstream of the gene.
###end p 45
###begin title 46
Authors' contributions
###end title 46
###begin p 47
###xml 197 203 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17</italic>
###xml 301 308 301 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17 </italic>
###xml 331 337 <span type="species:ncbi:9796">horses</span>
###xml 430 436 <span type="species:ncbi:9796">horses</span>
LSA identified and analyzed novel microsatellites including primer design, PCR and genotyping as well as genotyped a few of the previously identified markers in some of the families. LSA sequenced PMEL17, performed most of the linkage analysis and drafted the manuscript. RJ did initial genotyping of PMEL17 and collected DNA from horses used in the initial phase of the study. DTR phenotyped and collected blood samples from all horses. JE-B constructed the family pedigrees. SE initiated and designed the study, supplied the DNA along with detailed family and disease status data as well as provided valuable input and comments on the manuscript. GC initiated and designed the study, analyzed genetic markers and provided valuable input and comments on the manuscript. GL initiated and designed the study, supervised the molecular work in Uppsala, performed linkage analysis and edited and made improvements on the manuscript.
###end p 47
###begin p 48
All authors read and approved the final manuscript.
###end p 48
###begin title 49
Supplementary Material
###end title 49
###begin title 50
Additional File 1
###end title 50
###begin p 51
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Table 4.</bold>
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17</italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
Table 4. Primer sequences used to sequence PMEL17, not included in Brunberg et al. 2006
###end p 51
###begin p 52
Click here for file
###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
###xml 208 214 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PMEL17</italic>
###xml 526 527 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 376 381 <span type="species:ncbi:9606">human</span>
###xml 406 411 <span type="species:ncbi:9796">Horse</span>
We especially thank Dennis Shubitowski, Michigan State University, for administrating DNA samples and pedigree information. We are grateful to Emma Brunberg whom supplied most of the primers used to sequence PMEL17. We also like to acknowledge professor Leif Andersson for valuable input on the linkage analysis as well as Bengt Schepke, MD, for an excellent discussion about human ASD. The Rocky Mountain Horse Association provided information about the breed and anonymous breeders provided samples and the photo for Figure 2. We thank the Swedish University of Agricultural Sciences and the Knut and Alice Wallenberg foundation for a travel grant to LSA. Financial support was obtained from The Swedish Research Council Formas to GL.
###end p 54
###begin article-title 55
###xml 50 56 <span type="species:ncbi:9796">Horses</span>
Congenital ocular abnormalities of Rocky Mountain Horses
###end article-title 55
###begin article-title 56
###xml 82 88 <span type="species:ncbi:9796">horses</span>
Congenital ocular anomalies in purebred and crossbred Rocky and Kentucky Mountain horses in Canada
###end article-title 56
###begin article-title 57
Congenital ocular anomalies
###end article-title 57
###begin article-title 58
###xml 0 6 <span type="species:ncbi:9796">Equine</span>
Equine congenital defects
###end article-title 58
###begin article-title 59
###xml 55 61 <span type="species:ncbi:9796">horses</span>
###xml 69 74 <span type="species:ncbi:9796">horse</span>
Linkage of hyperkalaemic periodic paralysis in quarter horses to the horse adult skeletal muscle sodium channel gene
###end article-title 59
###begin article-title 60
###xml 0 6 <span type="species:ncbi:9796">Equine</span>
Equine severe combined immunodeficiency: a defect in V(D)J recombination and DNA-dependent protein kinase activity
###end article-title 60
###begin article-title 61
###xml 44 50 <span type="species:ncbi:9796">equine</span>
A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation
###end article-title 61
###begin article-title 62
The canine genome
###end article-title 62
###begin article-title 63
###xml 4 9 <span type="species:ncbi:9796">horse</span>
The horse homolog of congenital aniridia conforms to codominant inheritance
###end article-title 63
###begin article-title 64
###xml 88 94 <span type="species:ncbi:9796">Horses</span>
Corneal thickness, intraocular pressure, and optical corneal diameter in Rocky Mountain Horses with cornea globosa or clinically normal corneas
###end article-title 64
###begin article-title 65
###xml 78 83 <span type="species:ncbi:9796">horse</span>
A missense mutation in PMEL17 is associated with the Silver coat color in the horse
###end article-title 65
###begin article-title 66
###xml 52 59 <span type="species:ncbi:9031">chicken</span>
The Dominant white, Dun and Smoky color variants in chicken are associated with insertion/deletion polymorphisms in the PMEL17 gene
###end article-title 66
###begin article-title 67
###xml 116 125 <span type="species:ncbi:7955">zebrafish</span>
A mutation in the silver gene leads to defects in melanosome biogenesis and alterations in the visual system in the zebrafish mutant fading vision
###end article-title 67
###begin article-title 68
###xml 42 45 <span type="species:ncbi:9615">dog</span>
[Eye changes in the merle syndrome in the dog (author's transl)]
###end article-title 68
###begin article-title 69
###xml 71 74 <span type="species:ncbi:9615">dog</span>
Inheritance of microphthalmia with coloboma in the Australian shepherd dog
###end article-title 69
###begin article-title 70
###xml 86 89 <span type="species:ncbi:9615">dog</span>
Retrotransposon insertion in SILV is responsible for merle patterning of the domestic dog
###end article-title 70
###begin article-title 71
Documentation for CRI-MAP, version 2.4
###end article-title 71
###begin article-title 72
Ensembl
###end article-title 72
###begin article-title 73
###xml 28 34 <span type="species:ncbi:9796">equine</span>
Preliminary analysis of the equine genome sequence
###end article-title 73
###begin article-title 74
Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities
###end article-title 74
###begin article-title 75
Molecular and developmental mechanisms of anterior segment dysgenesis
###end article-title 75
###begin article-title 76
A new phenotype of recessively inherited foveal hypoplasia and anterior segment dysgenesis maps to a locus on chromosome 16q23.2-24.2
###end article-title 76
###begin article-title 77
UCSC Genome Browser
###end article-title 77
###begin article-title 78
Tandem repeats finder: a program to analyze DNA sequences
###end article-title 78
###begin article-title 79
Primer3 on the WWW for general users and for biologist programmers
###end article-title 79
###begin article-title 80
###xml 89 101 <span type="species:ncbi:9825">domestic pig</span>
Unexpectedly high allelic diversity at the KIT locus causing dominant white color in the domestic pig
###end article-title 80
###begin article-title 81
###xml 62 67 <span type="species:ncbi:9796">horse</span>
###xml 101 106 <span type="species:ncbi:9606">human</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
The first-generation whole-genome radiation hybrid map in the horse identifies conserved segments in human and mouse genomes
###end article-title 81
###begin article-title 82
###xml 76 82 <span type="species:ncbi:9796">equine</span>
Isolation, characterization and chromosome assignment of 341 newly isolated equine TKY microsatellite markers
###end article-title 82

